Primary medical therapy of micro- and macroprolactinomas in men*
N-acetyl cysteine (NAC) augmentation in the treatment of obsessive-compulsive disorder: a phase III, 20-week, double-blind, randomized, placebo-controlled trial
Tirzepatide for Adolescent Obesity What You Need to Know Before You Apply What is the purpose of this trial
Sarcopenia in type 2 Diabetes mellitus among Asian populations: prevalence and risk factors based on AWGS- 2019: a systematic review and meta-analysis
Remember, awareness and vigilant monitoring remain our best defense against preventable blindness.
274 A phase 2 study testing semaglutide enrolled 320 patients with MASH and fibrosis and randomized them to 0.1, 0.2, or 0.4 mg semaglutide group or the placebo group